Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Kala Pharmaceuticals Inc (NQ: KALA )

7.430 USD -0.030 (-0.40%)
Official Closing Price Updated: 7:51 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,528,200
Open 7.530
Bid (Size) 7.480 (2)
Ask (Size) 7.550 (10)
Prev. Close 7.460
Today's Range 7.390 - 7.560
52wk Range 5.040 - 14.68
Shares Outstanding 24,562,400
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in... 
From Business Wire News Releases
Kala Pharmaceuticals Announces Availability of EYSUVISTM for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline
Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced the... 
From Business Wire News Releases

Performance

YTD
+8.31%
+8.31%
1 Month
+2.06%
+2.06%
3 Month
-3.76%
-3.76%
6 Month
-19.59%
-19.59%
1 Year
+2.34%
+2.34%

More News

Read More
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in January
From Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Business Wire News Releases
Kala Pharmaceuticals Provides Update on Launch Plans for EYSUVISTM for the Treatment of Dry Eye Disease
From Business Wire News Releases
Kala Pharmaceuticals to Present at the Jefferies 2020 Virtual London Healthcare Conference
From Business Wire News Releases
Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From Business Wire News Releases
First Week of March 19th Options Trading For Kala Pharmaceuticals (KALA)
Tags Stocks
From Market News Video
Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call
From Business Wire News Releases
First Week of KALA July 2021 Options Trading
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X